SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Genematrix Revises GMAI-02 Phase 1 Expected End Date

Genematrix revised the expected end date for the GMAI-02 domestic Phase 1 trial to August 28, 2028, in a correction filing dated October 27, 2026.

Related stories